The trademark application RheumaTrace was filed by Nordic Bioscience A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). Application under examination.
It was designated 'Basic Application' for International Application 1782696 at the World Intellectual Property Organization (WIPO).
The application was filed in Danish (English was selected as the second language).
Change of name and address of the trademark registration was recorded on September 10, 2023.
The Refusal with reference B 018913624 was partially rejected according to Article 7(1)(b) EUTMR with decision issued on August 11, 2024 by the EUIPO.
Goods And Services
The mark was filed in class 5 with following description of goods:
Diagnostic biomarker reagents for medical and clinical purposes
Biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction
Biomarker assays to identify disease activity
Biomarker assays to quantify disease activity
Biomarker assays to analyse disease activity
Diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity
Medical diagnostic agents
Medical diagnostic reagents
Clinical diagnostic agents
Clinical diagnostic reagents
Diagnostic preparations, substances and materials
Medical diagnostic test strips
Diagnostic preparations for medical purposes
Diagnostic agents for medical use.
The mark was filed in class 42 with following description of goods:
Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity
Design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes
Design and development of biochemical, pharmaceutical, and medical assays
Design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction
Scientific and pharmaceutical research in the field of biomarkers and biomarker discovery
Identification of predictive and prognostic biomarkers for clinical trials
Identifing patients for clinical trials most likely to respond to a given treatment using biomarkers
Laboratory services relating to clinical trials
Clinical trials
Analysis of pharmacodynamic data
Analysis of data relating to biomarkers
Development of diagnostic preparations, equipment and tests
Clinical testing services
Diagnostic testing services
Testing services relating to the detection and measurement of biomarkers
Testing samples for the presence of biomarkers
Laboratory services
Medical laboratory services
Research laboratory services
Medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis
Advice, information and assistance relating to the foregoing.